Abiopharma

News list

📋 GARY A LYONS (Director) plans to sell 5K shares of TRAVERE THERAPEUTICS, INC. (at $62.14 each, total $311K) Filed: Aug 17, 2026 | ID: 008242

Full text

News bot Aug. 17, 2026, 8:32 p.m.
📋 Form 144 Filing: GARY A LYONS

Company: TRAVERE THERAPEUTICS, INC.

Filing Date: 2026-08-17

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 5,000
- Price per Share: $62.14
- Total Value: $310,700.00
- Planned Sale Date: 2026-08-17
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36257
- Issuer Contact Phone: 8889697879
- Issuer Address: 3611 Valley Centre Drive, Suite 300, San Diego, CA, 92130
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 94261082.0
- Number of Securities to be Sold: 1
- Signature: /s/ Gary A Lyons
- Plan Adoption Dates: 2026-05-18